- 2017 - 2020 Investigation of the immunotherapy targeting WT1 against grade 2/3 glioma and its promoting and inhibiting mechanism in the brain.
- 2014 - 2017 Combined WT1 vaccine immunotherapy and targeted chemotherapy against metastatic brain tumor
- 2011 - 2013 Investigation of the immunotherapy targeting WT1, and its promoting and inhibiting mechanism in the brain
- 2008 - 2010 Investigation of the immunotherapy targeting WT1 combined with chemotherapy against newly diagnosed malignant glioma.
- 2007 - 2008 Induction and characterization of WT1-specific Th1-type CD4(+) T cells to develop WT1 immunotherapy against malignant gliomas.
- 2007 - 2008 Expression analysis of TLR molecules in brain and neural stem cells
- 2005 - 2006 Development of blood-brain barrier permeable TAT chimera Interferon-β for the treatment of malignant gliomas.
- 2003 - 2004 Inhibition of glioma cell proliferation and invasion by neural stem cell factor and ex vivo gene therapy.
- 2001 - 2002 Regulation of cell cycle progression by ganglioside-a novel strategy against malignant glioma
- 2001 - 2002 Clinical application and functional analysis of MAGE E1 gene, glioma specific new gene belonging MAGE family
- 悪性グリオーマの病態解明と治療
- Molecular Pathological Evaluation of Malignant Brain Tumor
Show all